SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing heightened investor attention following a positive fireside chat at the CIBC Technology & Innovation Conference, where leadership highlighted profitable growth and a strong backlog in the QNX and secure communications divisions. The community is actively discussing the company's evolving role in the physical AI and robotics sectors, with many investors debating the long-term potential of the QNX operating system as a foundational element in high-performance edge computing.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing and several peers in the quantum sector are rallying on news that the U.S. government is committing roughly $2 billion in funding via the CHIPS Act, which includes equity stakes in participating companies. The community is actively debating the sustainability of these gains, with many traders discussing potential short squeezes versus concerns that the valuations are detached from current revenue levels and future dilution risks.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is seeing intense debate as investors weigh strong year-over-year growth in user assets and trading volume against a recent uptick in operating expenses and net losses. While some community members are accumulating shares in anticipation of the upcoming removal of day trading restrictions and active buyback programs, others remain skeptical, citing continued spending pressure and historical price volatility.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to a government-backed funding initiative involving CHIPS Act grants and equity stakes, sparking a massive surge in volume and intense short-squeeze speculation. While bulls are celebrating the sector validation and institutional momentum, skeptics are actively debating the sustainability of the valuation relative to the company's current revenue and cash burn.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies is trending due to its pivotal role as a primary hardware supplier in the AI infrastructure supercycle, with community discourse driven by significant institutional contracts and aggressive strategic expansions into agentic AI. Investors are actively debating the company's valuation as it integrates into the AI enterprise stack, with many closely tracking its supply chain partnerships and institutional flow.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is facing significant community debate and volatility following news that it was excluded from a recent multi-billion dollar government funding initiative, leading some investors to question its long-term leadership position compared to rivals who secured state backing. Despite these concerns, supporters remain highly optimistic, highlighting the company's substantial cash reserves, recent DARPA contracts, and strategic move to vertically integrate through the acquisition of SkyWater Technology as evidence of its continued dominance and resilience in the quantum sector.

Hyliion Holdings Corp. engages in the development of sustainable electricity-producing technology. It focuses on providing modular power plant technology that can operate on various fuel sources through the KARNO power module. The company was founded by Thomas J. Healy in 2015 and is headquartered in Cedar Park, TX.

Hyliion Holdings Corporation - Ordinary Shares - Class A

Hyliion Holdings Corp

Hyliion is experiencing a significant momentum shift as investors react to a breakout above multi-year price levels and heightened interest in the KARNO generator's potential within the AI data center, military, and distributed power sectors. The community is actively debating the company's transition from R&D to commercialization, with sentiment being driven by recent technical validation milestones, institutional activity, and the speculative possibility of near-term military and infrastructure contracts.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space is experiencing significant retail interest and volatility as investors speculate on the potential impact of a looming SpaceX IPO on the broader space infrastructure sector. While bulls are focused on recent partnership expansions and the company's supersonic testing capabilities, the community is deeply divided, with vocal bears highlighting concerns over pending SEC filing delays, cash burn, and looming insider lockup expirations.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with mobility drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, and taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting carriers with shippers on its platform, and gives carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Uber is trending ahead of its quarterly earnings release as investors weigh aggressive expansion into hotel bookings and delivery against competitive concerns in the autonomous vehicle sector. The community is actively debating the company's valuation and the potential for long-term growth versus persistent short-term price stagnation.

PicoCELA, Inc. engages in the manufacturing, installation, and services for enterprise wireless mesh solutions. It also offers wireless multi-hop relay devices. The company was founded by Hiroshi Furukawa on August 8, 2008 and is headquartered in Tokyo, Japan.

PicoCELA Inc - ADR

PicoCELA Inc. is experiencing intense retail momentum driven by its status as a low-float Japanese stock, with traders actively tracking its aggressive price volatility and frequent intraday halts. The community remains hyper-focused on its potential for rapid squeezes, though sentiment is split between those chasing the upward momentum and those warning of significant risks associated with the stock's high volatility and potential for quick pullbacks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Soligenix Announces Recent Updates and First Quarter 2026 Financial Results

Soligenix Announces Recent Updates and First Quarter 2026 Financial Results Soligenix Announces Recent Updates and First Quarter 2026 Financial Results PR Newswire PRINCETON, N.J., May 8, 2026...

LCID, SNGX, SRAD Stock Hit 52-Week Lows Today: What's Driving The Selloff? 

Equity

On Tuesday, LCID stock slipped 1%, marking its fifth straight session of losses, while SNGX plunged 70% and SRAD fell 11%.

SNGX Stock Slumps To Record Low After Lymphoma Trial Fails – All Eyes Now On Behçet’s Disease Treatment

An independent committee recommended stopping Soligenix’s late-stage trial to treat lymphoma due to a lack of effectiveness.

Why Is Soligenix Stock Sinking Tuesday?

Soligenix ends Phase 3 FLASH2 study for HyBryte. CEO cites unanticipated results. See how this impacts SNGX and next steps.read more...

Dow Gains 150 Points; Coca-Cola Posts Upbeat Earnings

US stocks mixed with Dow up 150 pts. Dow up 0.27%, NASDAQ down 1.06%, S&P 500 down 0.52%. Energy shares up 1.7%. Coca-Cola beats earnings & raises guidance. Baiya Int'l up 126%, Nexera up 63...

Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte in Treatment of Cutaneous T-Cell Lymphoma

Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial Evaluating HyBryte in Treatment of Cutaneous T-Cell Lymphoma Soligenix Announces Interim Results from the Phase 3 FLASH2 Trial...

Soligenix (NASDAQ: SNGX) Highlights Patient-Centric Drug Development Strategy Through Reformulation Approach

By Christopher J. Schaber,&#160;chairman, president, and CEO,&#160;Soligenix; published via Clinical Leader&#160; Soligenix&#160;(NASDAQ: SNGX)&#160;is emphasizing&#160;the strategic importance of patient-centric drug development, as outlined by CEO Christopher J. Schaber in a Clinical Leader guest column, which explores how reformulating therapies can improve access, adherence, and real-world viability. Drawing on the company’s experience with SGX945, Schaber explains that [&#8230;]

Soligenix (NASDAQ: SNGX) Strengthens Pipeline as European Commission Grants SGX945 Orphan Status

Recognition from global regulatory authorities can serve as a powerful validation of a therapy’s potential, particularly in the rare disease space where development challenges are significant and patient needs are urgent.&#160;Soligenix (NASDAQ: SNGX)&#160;has&#160;secured&#160;that type of validation, as the European Commission granted orphan drug designation to its investigational therapy SGX945 for the treatment of Behçet’s disease, [&#8230;]

Soligenix (NASDAQ: SNGX) Advances CTCL Research with Interim Analysis, Comparative Study Results

Advancing clinical research while generating positive data is a critical combination in biotechnology, particularly when addressing diseases with limited treatment options.&#160;Soligenix (NASDAQ: SNGX)&#160;is demonstrating that momentum as it provides&#160; both an encouraging&#160;clinical update&#160;from its phase 3 FLASH2 study and positive comparative&#160;clinical results&#160;for its HyBryte therapy, reinforcing the company’s focus on developing innovative treatments for serious [&#8230;]

Positive Clinical Results from HyBryte Comparative Study Evaluating HyBryte Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy

Positive Clinical Results from HyBryte Comparative Study Evaluating HyBryte Against Valchlor in the Treatment of Cutaneous T-Cell Lymphoma Published in Oncology and Therapy Positive Clinical Results...

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.

SNGX
Soligenix Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest SNGX News

SNGXSoligenix Inc